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age group (< 18, 18–34, 35+), race, ethnicity, number of high-risk diagnosis codes, 
and zip codes. High-risk diagnoses—including prior history of preterm delivery, 
insulin-dependent diabetes, hypertension, multiple gestations, and incompetent 
cervix—are known predictors of low birth weight and premature delivery. Results: 
Thirty-one participants at high-risk for premature delivery received cell phones and 
text-messaging services. Twenty-six mothers (84%) successfully delivered babies to 
term (< 31 days from expected delivery date). Babies born in the IG had higher birth 
weights than those born in the CG (mean, 38.71g), lower rates of low birth weight 
babies (-0.12%) and very low birth weight babies (-0.06%), and delivered almost a 
full week later (mean, 0.96 wk). Participants reported high program-satisfaction 
rates. ConClusions: Members at high risk for preterm delivery participating in 
Moms2B had superior pregnancy outcomes compared to nonparticipants; program 
satisfaction was favorable.
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researcH fOr lng-Ius 13.5 mg cOntracePtIVe
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objeCtives: To apply value of information analysis (VoI) to a cost-effectiveness 
model of a Levonorgestrel intrauterine system LNG-IUS 13.5mg (total content) in 
order to identify parameters worth investigating to reduce remaining uncertainty 
around the reimbursement decision. LNG-IUS 13.5mg is a novel low-dose hormonal 
intrauterine contraceptive system for up to 3 years use and was shown to be cost-
effective over this horizon vs. commonly used short-acting contraceptive methods 
in women aged 20-29. Methods: VoI analyses were performed using an exist-
ing US cost-effectiveness model with LNG-IUS 13.5mg. Expected Value of Perfect 
Information (EVPI) and the parameter EVPIs (EVPPI) for the following groups were 
estimated: probability of failure (unintended pregnancy (UP)); probability of discon-
tinuation during year 1 and subsequent years; and follow-up consultation costs. 
Individual EVPPIs were calculated for probability of failure of injectable contracep-
tives and LNG-IUS 13.5mg and first year discontinuation probability of LNG-IUS 
13.5mg. EVP(P)I were calculated using different willingness to pay (WTP) values for 
an UP and extrapolated to population values. Results: The estimated EVPI was 
$69, $62 and $40 at WTP of $300, $400 and $700 per UP, respectively. EVPPI analysis 
suggested that probabilities of failure and first year discontinuation were the most 
influential, accounting for the majority of uncertainty of the reimbursement deci-
sion. Population EVPI estimates suggested that further research in this area was 
potentially worthwhile. ConClusions: Comparative effectiveness research focus-
ing on the failure rate of injectable contraceptives and the first year discontinuation 
rate of LNG-IUS 13.5mg is potentially worthwhile. Expected value of sample informa-
tion will have to be compared to the actual costs of such research.
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objeCtives: The paucity of pediatric information available on drug labels has-
tened calls for regulatory intervention aimed at providing clinicians with improved 
information to treat pediatric populations, especially neonates. This study exam-
ined how neonatal drug data is presented on labels for approved drugs over the 
past 30 years. Methods: This study included review of publicly available data 
retrieved from the FDA website Drugs@FDA. Three sections of the FDA approved 
label were analyzed for mention of neonates; “Indication and Usage”, “Dosage and 
Administration” and “Pediatric Use”. “Neonates” were defined as infants age 0-28 
days and/or specifically cited as “neonates” or “newborns”. This analysis did not 
include label information pertinent to in utero exposure to drug. Descriptive sta-
tistics were performed and the pharmaceutical active ingredient was the unit of 
analysis. Results: The study included all NDA/BLA approvals by the FDA between 
January 1, 1980 and December 31, 2012 and available on the Drugs@FDA website 
(n= 676). Eleven (1.6%) labels included neonate information in the Indications and 
Usage section, 33 (4.9%) in the Dosage and Administration section and 62 (9.2%) 
in the Pediatric Use section. References to neonates occurred in two sections on 2 
labels (0.3%) and in all three sections on 5 labels (0.7%). Statements that the drug 
was not studied and/or not recommended in neonates were most often found in the 
Pediatric Use section (528, 78%), but also noted in the Dosage and Administration 
section (22, 3.3%) and the Indications and Usage section (9, 1.3%). ConClusions: 
This study demonstrates that data necessary to determine the appropriateness 
of medications in neonates is difficult to find, even when available to clinicians. 
As regulators consider how to improve the quantity and quality of neonatal drug 
data, consideration should be given to standardizing neonatal information on drug 
labels, thereby ensuring that regulatory efforts to incentivize pediatric research 
are optimized.
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objeCtives: Orofacial clefts (OFC) are among the most common birth defects and 
often require hospitalizations during early childhood. We assessed health care 
utilization and costs for children during 2010. Methods: Data were extracted 
from the 2006-2010 MarketScan® Commercial claims databases to identify children 
with ≥ 2 outpatient claims or ≥ 1 inpatient claim for OFC during those five years 
to maximize case ascertainment. Health care utilization and costs during 2010 
3) Brief COPE Scale (higher scores = better coping); 4) Acculturative Stress (ASSIS) 
(higher scores = higher stress) [For international students only] and; 5) demographic 
information. Results: The mean age of the 19 participants was 28.9 years ± 4.6. A 
majority of the respondents were Asian (47.4%), female (73.7%), enrolled in the PhD 
program (73.7%), single (52.6%), international students (57.9%) and lived with family 
(47.4%). Mean PCS and MCS were 49.97 ± 9.3 and 49.97 ± 8.22, respectively, indicating 
that both the physical health and mental health summary scores were comparable 
to the general population. Overall, participants reported low stress (GSI-R) levels 
(mean= 56.53 ± 20.3; range 21 – 147)) and engaged in mid-range levels of coping 
mechanisms to deal with stress (mean= 71.42 ± 7.1; range 28 – 140). Among inter-
national students, acculturative stress levels (mean= 51.10 ± 27.9; range 36 – 180) 
were low. ConClusions: There is a paucity of quantitative data for perceived stress 
among graduate students. The results from this pilot study will be used to imple-
ment a future survey among a larger and more diverse sample of graduate students.
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a sImPle anD effectIVe aPPrOacH fOr analyzIng multIVarIate 
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objeCtives: The purpose of this paper is to propose a simple and efficient approach 
for analyzing multivariate longitudinal data (MLD), such as longitudinal health-
related quality of life (HRQoL) assessments in observational studies. This will be 
accomplished using the combination of two popular statistical methods for causal 
inference and multivariate data, namely the inverse probability-weighted (IPW) esti-
mator and principal component analysis (PCA). Methods: Multivariate outcomes 
at each time point will be converted to the first principal component score (FPCS) for 
each subject. Then all FPCS will be composited into a numerical observation using 
the area under a curve (AUC). The IPW estimator is used to compare the difference 
between the two treatments in terms of the estimated AUCs. Finally, the proposed 
method will be applied to a simulated dataset to determine if there is significant 
difference between two treatments. Results: The statistical results show that the 
95% bootstrap percentile confidence interval (BPCI) is (-3.06, -3.59). Since the BPCI 
does not contain zero, we claim that the treated group (M= 1) is significantly differ-
ent from the control group (M= 0) at a 5% level in overall longitudinal multivariate 
health outcomes. ConClusions: In this paper, we propose a simple and efficient 
approach to overcome the difficulty of analyzing MLD in practice. We demonstrate 
how to use our proposed method with a simulated dataset. Our simulated data set 
allowed us to demonstrate how our proposed method may be particularly useful 
for analyzing longitudinal HRQoL assessments in medical studies.
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assessment Of meDIcal anD PHarmacy stuDents’ KnOWleDge anD 
PercePtIOns abOut generIc meDIcInes anD tHeIr QualIty anD PrIces In 
Kabul – afgHanIstan
Bashaar M., Ahmad Hassali M.A.
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objeCtives: To assess medical and pharmacy students’ knowledge and perception 
about generic medicines and its quality and prices in Kabul- Afghanistan. Methods: 
A questionnaire based convenience sample of 255 was applied and study was con-
ducted at Kabul Medical University and Pharmacy Faculty of Kabul University. The 
questionnaire had 19 questions and was designed in two sections (definition of 
generic and branded medicine and perception towards generic medicine). A total 
of 95 pharmacy and 125 medical students had voluntarily participated in the sur-
vey. SPSS version 16 was used for data analysis purposes. Results: Among the 
total target n = 220 (response rate 86.27%) students voluntarily participated in the 
survey and n = 27 (28.42%) of the pharmacy students were working as pharmacists 
in the private pharmacy outlets. In reference to the knowledge about generic medi-
cines n = 173 (67.84%) of the respondents had knowledge about generic medicines. 
The interviewees n = 205 (80.39%) expressed that the quality is their major con-
cern, when buying generic medicines. Both groups have shown unanimity n= 216 
(84.70%) that prescription of generic medicines promotes cost containment among 
the patient. ConClusions: The current study emphasizes that awareness and 
knowledge about generic medicines by including special topics in the medical and 
pharmacy curriculum is important and further promoting culture of prescribing 
generic medicines in daily practice.
InDIVIDual’s HealtH – Health care use & Policy studies
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mOms2b: ImPrOVIng bIrtH OutcOmes tHrOugH use Of cell PHOnes, 
textIng, anD IntensIVe case management
Grant M., Stango D.A., Anthony D., Dinsmore S., Keleti D., Michael K.E., Tan-Torres S.
AmeriHealth Caritas Family of Companies, Philadelphia, PA, USA
objeCtives: Out of 200 of the most populous U.S. counties, Philadelphia has the 
fifth highest infant mortality rate. Keystone First partnered with Verizon Wireless 
to launch Moms2B—a program providing free cell phones and minutes to directly 
engage Keystone First’s high-risk pregnant Medicaid members. The goals are to 
improve prenatal care and health outcomes, and keep members connected to 
the plan’s Bright Start® maternity program. Methods: The Bright Start Care 
Management team contacted participants on the cell phones to provide coach-
ing and care coordination during pregnancy and postpartum. Participants also 
received text messages with nutritional and clinical information specific to gesta-
tional age. In addition, they received encouragement and gift incentives to main-
tain scheduled prenatal/postpartum care, along with information about screenings, 
and educational and community-based programs. Seventeen participants actively 
engaged in Moms2B (intervention group: IG) were risk-matched to 17 nonparticipat-
ing high-risk pregnant members (control group: CG). Matching variables included 
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objeCtives: Safety and effective use of drugs depend on prescribing pattern. 
Irrational prescription of drugs is responsible for delay in relief, more adverse 
effects, prolonged hospitalization, increased morbidity and mortality, emergence 
of microbial resistance and financial loss. The aim of this study was to analyze 
the prescribing pattern in a private paediatric outpatient setting. Methods: 
A prospective observational study was carried out at a private paediatric out-
patient clinic to analyze the drug utilization using WHO prescribing indicators. 
A structured data collection format was used to obtain data from prescrip-
tions. Results: The results are based on data obtained from 653 patient’s pre-
scriptions; out of which 60 patients were excluded. A total of 593 patients were 
included in the study. Of these, 356 were boys and 237 were girls. The average 
number of drugs per prescription was found to be 3.16±0.05. Drugs prescribed 
by generic name were only 6.5%. Thirty percent of medicines were prescribed 
from National list of essential medicines. The percentage encounter with an 
antibiotic and injection prescribed was 22% and 0.5%, respectively. The results 
are indicative of a judicious choice of drugs for children in an outpatient set-
ting. ConClusions: The results provide continuing evidence for the safe pre-
scribing of drugs to children.
PIH84
cOmParIsOn Of tOOls tO eValuate PrescrIbIng In tHe elDerly
Kashyap M.1, D’cruz S.2, Sachdev A.2, Tiwari P.3
1CRIUGM, Montreal University, Montreal, QC, Canada, 2Government Medical College & Hospital, 
Chandigarh, India, 3National Institute of Pharmaceutical Education and Research (NIPER), S.A.S 
Nagar, India
objeCtives: To compare the level of inappropriate prescribing (IP) using the dif-
ferent IP screening tools in a given sample and to match the findings with real 
time findings of local practice. Methods: 1 year prospective interventional study, 
elderly inpatients of age 60 yrs or older of either sex (n= 500); outcome measures-5 
different IP screening tools {Improved Prescribing in the Elderly Tool (IPET) 2000, 
Zhan criteria 2001, Modified Beers’ criteria 2003, Health Plan Employer Data and 
Information Set (HEDIS) 2006 and Screening Tool of Older People’s potentially inap-
propriate Prescriptions (STOPP) criteria} and changes in therapy based on real time 
practice. Results: 500 randomly selected prescriptions out of data pool of 1000 
patients’ record were subjected to 5 different IP screening tools. The average age 
of the patients was 66.3±0.3 and prescribed 8.9±0.2 drugs. The level of IP observed 
according to different tools were 29% (Beers’ 2003)> 23.6% (STOPP criteria)> 11.8% 
(HEDIS)> 8% (Zhan criteria)> 4.2% (IPET). The IP identified according to real time 
practice was 14.4% which closely matched with IP identified by HEDIS criteria. The 
most common inappropriate drugs accepted by physicians were administration 
of anticoagulant therapy with aspirin, Diazepam, Digoxin, Diltiazem, Codein and 
Ferrous Sulfate. The Beers’ criteria 2003 identified significantly higher level of IP 
than other criteria. The higher dose of ferrous sulfate (n= 38) was most common 
drug contributed to higher level of IP. Only 11 prescriptions out of 38 considered 
Inappropriate Drug (ID) in real time practice. Like wise, other most contributing 
drugs were Nitrofurantoin (2 out of 17 accepted ID in real practice) and chlorphen-
armine (none out of 12 accepted ID in real practice). ConClusions: The authors 
suggest merging the two criteria (Beers’ criteria and STOPP criteria) with list of 
drug identified inappropriate from real patient care setting for assessment of level 
of IP in Indian setting
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cOmParIsOn Of beers crIterIa 2012 anD beers crIterIa 2003 fOr 
meDIcatIOn use In tHe elDerly
Boya C.1, Tiwari P.2, D’cruz S.3, Sachdev A.3
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objeCtives: Use of potentially inappropriate medications (PIM) among the elderly 
is a serious public health problem because it is intrinsically linked to increased 
morbidity and mortality, causing the high costs to public health systems. The objec-
tive of this study was to compare the prevalence of PIM prescribing in elderly inpa-
tients using the modified American Geriatrics Society (AGS) updated Beers criteria 
2012 and same comparing with the Beers criteria 2003. Methods: The prospective 
observational study was carried out at a public teaching hospital. Prescriptions 
of elderly inpatients aged 60 years and above were collected and analyzed. PIMs 
were identified with the help of Beers criteria 2012 and Beers criteria 2003 and 
comparison was made between two criteria. Results: The results were based on 
data of 214 patients. 57% patients were male; and, 61% were aged between 60–69 
years with the average age of 68 years. The average number of diagnoses and medi-
cations were three and eight, respectively. A total of 44 patients were prescribed 
with at least 1 PIM according to Beers criteria 2012, compared with 37 patients 
according to Beers criteria 2003. In 2012 Beers criteria, benzodiazepines were found 
most prevalent PIMs whereas in 2003 Beers criteria they were found to be low. 
Theophyline was found to be high prevalent in Beers criteria 2003 than Beers cri-
teria 2012. ConClusions: Beers criteria 2012 are effective in identifying the PIMs 
than Beers criteria 2003.
PIH86
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large cOmmunIty-DWellIng OlDer POPulatIOn: a cOHOrt stuDy
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objeCtives: The prescription of potentially inappropriate medications (PIMs) for 
older adults is a well-known public health concern. Updated country-specific esti-
mates of inappropriate prescribing in older adults using germane explicit criteria are 
needed to facilitate physician-tailored quality improvement strategies. Therefore, 
were assessed for 3,875,237 children ≤ 10 years of age with continuous enroll-
ment, including 4,964 children with OFC (cases) and 3,870,273 children without 
birth defects and select genetic diseases (controls). Costs were categorized into 
inpatient, emergency department, non-emergency department outpatient, other 
medical services, and prescription drugs. OFC-related costs were claims with a 
primary or secondary OFC diagnosis code, whereas total health care costs included 
all claims for 2010. Results were stratified by cleft type, isolated (no other major 
birth defect) vs. non-isolated OFC, and child’s age. Results: Of 4,964 children 
with OFC, 10.3% had cleft palate only, 3.3% had cleft lip only, 86.4% had cleft lip 
with cleft palate; 86.9% had isolated OFC. Case children had significantly higher 
mean total costs, $14,962 ($52,380 with non-isolated and $9,314 with isolated OFC), 
compared to $1,718 for control children. The mean cost difference between case 
and control children was $13,244 for overall OFC and $7,596 for isolated OFC. The 
mean OFC-related health care cost for all children was $6,839. Among children 
with OFC, mean costs for infants were approximately four and six times greater 
than costs for 1-5 year olds and 6-10 year olds, respectively. ConClusions: Health 
care utilization and costs are high for children with OFC, particularly for those 
with additional birth defects, and are greater during infancy than among older 
age groups. This analysis only includes direct, medical costs and therefore under-
estimates the total cost of care for children with OFC.
PIH81
aDDressIng maternal mOrtalIty anD near mIss tHrOugH tHe 
eVIDence-InfOrmeD POlIcy netWOrK brazIl
Brito G.V.1, Vieira N.C.1, Souza N.M.1, AlvesM.D.S.N. 1, EliasF.T.S. 2
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bACkgRound: Persistent high rates of maternal mortality and near miss remain 
a major problem in low-and middle income countries. In Brazil, this problem has 
being since late1980s when information and surveillance systems and access to 
improved health care services were strengthened. Such efforts led to a 51% reduc-
tion in maternal mortality rate (141 in 1990 and 68 deaths/100,000 born alive in 
2010). Nevertheless, Brazil must improve to meet its Millennium Development 
Goal of 35 deaths by 2015. In 2011, the Brazilian government launched the “Stork 
Healthcare Network” (Rede Cegonha) to ensure women the right to reproductive 
planning, humanized care to pregnancy, childbirth and postpartum periods, and the 
right to children safe birth, healthy growth and development. The Department of 
Science and Technology of Brazilian Ministry of Health is linking Health Technology 
Assessment with the Evidence-Informed Policy Network (EVIPNet Brazil) to optimize 
implementation of Stork Network’s programs and its improvement. objeCtives: 
To describe EVIPNet Brazil’s strategies to optimize the Stork Healthcare Network 
on maternal care by supporting the use of evidence and values in decision making 
in the Brazilian Health System (SUS). Methods: AND Results: EVIPNet Brazil 
developed two main short-term initiatives. First, it convened a workshop with key 
researchers and government officials to: 1) produce a policy brief of the best evi-
dence on maternal mortality and near miss, and 2) foster exchange among dif-
ferent government units and academia. Second, it plans to organize national and 
regional deliberative dialogues with stakeholders as to embed decision makers’ 
tacit knowledge and experiences into the policy brief, a crucial step towards moving 
evidence into action. ConClusions: Engaging key stakeholders and promoting 
evidence-informed policy making may lead Brazil to reduce maternal mortality 
and near miss rates to levels that are compatible to its current social and economic 
development. KEYWORDS: Maternal Mortality; Health systems; Systematic Review; 
Research Evidence
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cOmParatIVe cOsts Of tWO InnOVatIVe tecHnIQues fOr grOWIng rODs
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objeCtives: Many types of severe or progressive spinal deformities can be safely 
treated with surgery. Vertical expandable prosthetic titanium Rib (VEPTR) devices 
are growing rods designed to mechanically stabilize and distract the thorax to cor-
rect three-dimensional thoracic deformities. This design allows expansion and 
anatomic distraction but impose replacement of components through surgery. 
With the motorized growing rods, elongation occurs without surgery. The aim of 
this study is to estimate and compare direct medical costs with VEPTR and motor-
ized growing rods. Methods: A retrospective study was conducted in pediatric 
orthopedic surgery department to estimate direct medical costs in 10 children 
treated with VEPTR technique and 7 children treated with motorized growing rods. 
Costs collection was conducted over a period of one year. This economic analysis 
adopted the health care payer’s perspective and took into account hospital stays, 
medical devices, medical consultations and radiographic examinations. Descriptive 
analysis of quantitative variables, a mean comparison and a univariate sensitivity 
analysis were performed. Results: There were 30% of girls in the VEPTR group 
and 71% in the motorized group. The implantation mean age was 9 years old in 
VEPTR and 6 years old in the other group. There was more syndromic scoliosis 
(86% vs. 40%) in motorized growing rods than congenital scoliosis. Average direct 
medical costs are 21 461€ in VEPTR group vs. 29797€ in motorized growing rods 
group. The costs associated with medical device are higher in motorized growing 
rod group. ConClusions: Total costs were equivalent in both groups. However, 
motorized implants avoid hospital stays for surgery. The costs avoided would be 
visible if the follow-up after implantation was longer.
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